Highlights from DCAT Week 2026
March 31, 2026
CPC Scientific had a wonderful time returning to New York for DCAT Week 2026! From March 23–26, it was a pleasure to connect with partners, clients, and industry peers across a dynamic week of highlighting our state-of-the-art commercial production and generic API scale-up capabilities.
Thank you to everyone who met with our team in New York and joined us for the 98th DCAT Annual Dinner!
Strategic Partner Dialogue Across DCAT Week 2026
We were proud to be represented throughout the week by:
- Shawn Lee, PhD – CEO & Founder
- Theresa Cheng – President
- Howard Huang, MS – Senior Vice President of Business Development
- Tim Nieters, MBA – Senior Vice President of Strategic Portfolio
In Suite #3712 at the Lotte Palace, our team welcomed guests for strategic dialogues on CPC Scientific’s manufacturing expertise, including our expanding US manufacturing footprint, support of over 300 NCE and generic pipelines, and more. The conversations carried into the DCAT Annual Dinner, where we had a fantastic evening hosting our guests at Table #79 on the ballroom floor.
Generic API & Peptide Manufacturing Momentum
This year’s discussions reflected a clear market priority: the need for CDMO partners that can combine technical depth with quality, global compliance, and the large-scale capacity to support programs from development through commercial supply. Key themes included:
- Integrated GMP peptide and oligonucleotide manufacturing platforms to support late-phase and commercial programs
- NCE development and generic API scale-up, amid growing demand from GLP-1 and therapeutic API pipelines
- CPC Scientific’s upcoming Rocklin, California manufacturing site and its role in diversifying a more resilient global API supply chain
As we celebrate 25 years of CDMO excellence in 2026, DCAT Week has served as a strong reminder of the strategic partnerships, scientific leadership, and sustained innovation behind our global legacy. Those strengths continue to guide us in our enduring mission to help bring life-changing therapies to patients worldwide.
We’re truly grateful for the connections and momentum that made this year’s DCAT Week so memorable, and we look forward to continuing those dialogues well beyond New York!
Ready to partner with a peptide & oligo CDMO built for scale?
Connect with CPC Scientific to explore our scalable API manufacturing support across the full development lifecycle.
Latest News & Resources
Catch CPC Scientific's key moments from NextGen Biomed 2026, where we showcased how our advanced process design is accelerating production timelines and cost efficiency for greener TIDES manufacturing at scale...
Construction begins on CPC Scientific’s 41,000 sq ft building in Rocklin to establish a new Center of Excellence for Peptide Manufacturing.
CPC Scientific is thrilled to return to CPHI Frankfurt 2025! Explore our booth as we recap key moments from Day 1 of CPHI, where we're highlighting our position as a globally pioneering peptide & oligo CDMO...
CPC Scientific is back at Boulder Peptide Symposium 2025 as a Gold Sponsor! Discover key moments from the symposium and see how our team is pioneering innovations in large-scale peptide synthesis...
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the Hong Kong Stock Exchange!
Catch the key moments from CPC Scientific's 2025 annual gathering! Our CEO Shawn Lee, PhD kicked off the meeting by providing valuable insights into the company's progress, highlighting our recent achievements, and sharing exciting developments on the horizon...
Catch CPC Scientific's key moments from NextGen Biomed 2026, where we showcased how our advanced process design is accelerating production timelines and cost efficiency for greener TIDES manufacturing at scale...
Construction begins on CPC Scientific’s 41,000 sq ft building in Rocklin to establish a new Center of Excellence for Peptide Manufacturing.
CPC Scientific is thrilled to return to CPHI Frankfurt 2025! Explore our booth as we recap key moments from Day 1 of CPHI, where we're highlighting our position as a globally pioneering peptide & oligo CDMO...
CPC Scientific is back at Boulder Peptide Symposium 2025 as a Gold Sponsor! Discover key moments from the symposium and see how our team is pioneering innovations in large-scale peptide synthesis...
Join us as we celebrate a proud milestone: the successful listing of Medtide Inc., parent company of CPC Scientific, on the Hong Kong Stock Exchange!
Catch the key moments from CPC Scientific's 2025 annual gathering! Our CEO Shawn Lee, PhD kicked off the meeting by providing valuable insights into the company's progress, highlighting our recent achievements, and sharing exciting developments on the horizon...